Turicibacter and Acidaminococcus Predict Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitor.
Frontiers in Immunology(2023)
Key words
clinical efficacy,gut microbiota,immune checkpoint inhibitors,immune-related adverse events,PD-1 inhibitor,Turicibacter,Acidaminococcus
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined